artificial intelligence
Caris Life Sciences, ConcertAI Partner on Molecular Oncology R&D Platform
Caris and ConcertAI will combine their multiomic and multimodal databases and AI technology to create a unified platform for use in oncology and hematology.
AstraZeneca to Evaluate C2i Genomics' Cancer Detection, Monitoring Platform
AstraZeneca will assess the startup's test on patient-derived samples, following a previous collaboration that used artificially generated samples.
Envisagenics, Cancer Research UK, Queen Mary University Collaborate on AML Drug R&D
Cold Spring Harbor spinout Envisagenics will apply its AI technology to multiomics data in pursuit of new therapies for acute myeloid leukemia and other hematopoietic cancers.
NTU-Singapore Launches S$160M Institute for Digital Molecular Analytics and Science
The institute will focus on "digital molecular analytics," a new way of detecting, identifying, and quantifying biomolecules at the single-molecular level by bridging biology and information technology.
Envisagenics, Bristol Myers Squibb Partner to ID Cancer Therapy Alternative Splice Targets
Envisagenics will use its SpliceCore platform to identify alternative splicing-derived therapeutic targets for BMS's cancer pipeline.